Literature DB >> 19586156

Beliefs and attitudes about bupropion: implications for medication adherence and smoking cessation treatment.

Lisa M Fucito1, Benjamin A Toll, Peter Salovey, Stephanie S O'Malley.   

Abstract

Beliefs about medication are associated with treatment adherence and outcome. This is a secondary analysis of the role of beliefs and attitudes about bupropion in treatment adherence and smoking cessation outcomes using data from a smoking cessation trial of open-label sustained-release (SR) bupropion therapy reported previously (Toll et al., 2007). Positive beliefs and attitudes were positively correlated with intentions, desire, confidence, and motivation to quit smoking; expectation of quitting success; perceived benefits of quitting; and perceived disadvantages of smoking. Positive beliefs were also associated with greater medication adherence, an increased likelihood of completing treatment and being continuously abstinent, and a delayed latency to smoking lapse. These findings provide preliminary support that positive beliefs and attitudes about bupropion are associated with positive attitudes toward quitting, better treatment adherence, and potentially better treatment response. Copyright (c) 2009 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19586156      PMCID: PMC3094849          DOI: 10.1037/a0015695

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  40 in total

1.  Biochemical verification of tobacco use and cessation.

Authors: 
Journal:  Nicotine Tob Res       Date:  2002-05       Impact factor: 4.244

2.  Mediating mechanisms for the impact of bupropion in smoking cessation treatment.

Authors:  Caryn Lerman; David Roth; Vyga Kaufmann; Janet Audrain; Larry Hawk; Aiyi Liu; Ray Niaura; Leonard Epstein
Journal:  Drug Alcohol Depend       Date:  2002-07-01       Impact factor: 4.492

3.  Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public.

Authors:  J F Etter; T V Perneger
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

4.  Effects of gender on relapse prevention in smokers treated with bupropion SR.

Authors:  David Gonzales; Wendy Bjornson; Michael J Durcan; Jonathan D White; J Andrew Johnston; A Sonia Buist; David P L Sachs; Nancy A Rigotti; Raymond Niaura; J Taylor Hays; Richard D Hurt
Journal:  Am J Prev Med       Date:  2002-05       Impact factor: 5.043

5.  Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial.

Authors:  D Tashkin; R Kanner; W Bailey; S Buist; P Anderson; M Nides; D Gonzales; G Dozier; M K Patel; B Jamerson
Journal:  Lancet       Date:  2001-05-19       Impact factor: 79.321

6.  A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder.

Authors:  M A Hertzberg; S D Moore; M E Feldman; J C Beckham
Journal:  J Clin Psychopharmacol       Date:  2001-02       Impact factor: 3.153

7.  The effect of bupropion on nicotine craving and withdrawal.

Authors:  S Shiffman; J A Johnston; M Khayrallah; C A Elash; C J Gwaltney; J A Paty; M Gnys; G Evoniuk; J DeVeaugh-Geiss
Journal:  Psychopharmacology (Berl)       Date:  2000-01       Impact factor: 4.530

8.  Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

Authors:  S Tonstad; C Farsang; G Klaene; K Lewis; A Manolis; A P Perruchoud; C Silagy; P I van Spiegel; C Astbury; A Hider; R Sweet
Journal:  Eur Heart J       Date:  2003-05       Impact factor: 29.983

9.  A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.

Authors:  P Tønnesen; S Tonstad; A Hjalmarson; F Lebargy; P I Van Spiegel; A Hider; R Sweet; J Townsend
Journal:  J Intern Med       Date:  2003-08       Impact factor: 8.989

10.  Psychological intervention and antidepressant treatment in smoking cessation.

Authors:  Sharon M Hall; Gary L Humfleet; Victor I Reus; Ricardo F Muñoz; Diane T Hartz; Roland Maude-Griffin
Journal:  Arch Gen Psychiatry       Date:  2002-10
View more
  15 in total

1.  Perceived medication assignment during a placebo-controlled laboratory study of varenicline: temporal associations of treatment expectancies with smoking-related outcomes.

Authors:  John B Correa; Bryan W Heckman; Nicole S Marquinez; David J Drobes; Marina Unrod; Richard G Roetzheim; Thomas H Brandon
Journal:  Psychopharmacology (Berl)       Date:  2014-01-10       Impact factor: 4.530

Review 2.  Pharmacotherapy for smoking cessation: current advances and research topics.

Authors:  Tobias Raupach; Constant P van Schayck
Journal:  CNS Drugs       Date:  2011-05       Impact factor: 5.749

3.  Bupropion sustained release for pregnant smokers: a randomized, placebo-controlled trial.

Authors:  Tatiana N Nanovskaya; Cheryl Oncken; Valentina M Fokina; Richard S Feinn; Shannon M Clark; Holly West; Sunil K Jain; Mahmoud S Ahmed; Gary D V Hankins
Journal:  Am J Obstet Gynecol       Date:  2016-11-25       Impact factor: 8.661

Review 4.  Adherence to Pharmacological Smoking Cessation Interventions: A Literature Review and Synthesis of Correlates and Barriers.

Authors:  Lauren R Pacek; F Joseph McClernon; Hayden B Bosworth
Journal:  Nicotine Tob Res       Date:  2018-09-04       Impact factor: 4.244

5.  Correlates of Adherence to Varenicline Among HIV+ Smokers.

Authors:  Donna Shelley; Tuo-Yen Tseng; Mirelis Gonzalez; Paul Krebs; Selena Wong; Robert Furberg; Scott Sherman; Antoinette Schoenthaler; Anthony Urbina; Charles M Cleland
Journal:  Nicotine Tob Res       Date:  2015-08       Impact factor: 4.244

6.  Adherence to varenicline in the COMPASS smoking cessation intervention trial.

Authors:  Sheryl L Catz; Lisa M Jack; Jennifer B McClure; Harold S Javitz; Mona Deprey; Susan M Zbikowski; Tim McAfee; Julie Richards; Gary E Swan
Journal:  Nicotine Tob Res       Date:  2011-02-24       Impact factor: 4.244

7.  Smokers' Treatment Expectancies Predict Smoking Cessation Success.

Authors:  Lisa M Fucito; Benjamin A Toll; Corey R Roos; Andrea C King
Journal:  J Smok Cessat       Date:  2014-08-27

8.  Combining Text Messaging and Telephone Counseling to Increase Varenicline Adherence and Smoking Abstinence Among Cigarette Smokers Living with HIV: A Randomized Controlled Study.

Authors:  Tuo-Yen Tseng; Paul Krebs; Antoinette Schoenthaler; Selena Wong; Scott Sherman; Mirelis Gonzalez; Antonio Urbina; Charles M Cleland; Donna Shelley
Journal:  AIDS Behav       Date:  2017-07

9.  "Isn't there a bunch of side effects?": A focus group study on the beliefs about cessation treatments of non-college educated young adult smokers.

Authors:  Danielle A Duarte; Julia Cen Chen-Sankey; Kathleen Dang; Leah Orozco; Bambi Jewett; Kelvin Choi
Journal:  J Subst Abuse Treat       Date:  2020-01-24

10.  Factors associated with discontinuation of bupropion and counseling among African American light smokers in a randomized clinical trial.

Authors:  Nicole L Nollen; Matthew S Mayo; Jasjit S Ahluwalia; Rachel F Tyndale; Neal L Benowitz; Babalola Faseru; Taneisha S Buchanan; Lisa Sanderson Cox
Journal:  Ann Behav Med       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.